Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph C Loftus

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Oncotarget|January 20, 2017
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cellsAlison Roos, Harshil D Dhruv, Ian T Mathews, et al.
International Journal of Molecular Sciences|June 19, 2024
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in GlioblastomaMylan R Blomquist, Ryan Eghlimi, Angad Beniwal, et al.
Circulation Research|March 9, 2002
Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failureShaw-Yung Shai, Alice E Harpf, Christopher J Babbitt, et al.
Science Signaling|August 14, 2014
Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastomaYael Kusne, Eugenio A Carrera-Silva, Anthony S Perry, et al.
Cancer Research|October 5, 2006
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcomeNhan L Tran, Wendy S McDonough, Benjamin A Savitch, et al.
Journal of Translational Medicine|October 22, 2025
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppressionMylan R Blomquist, Teresa M R Noviello, Christopher Sereduk, et al.
Neuro-Oncology|August 10, 2016
Radiogenomics to characterize regional genetic heterogeneity in glioblastomaLeland S Hu, Shuluo Ning, Jennifer M Eschbacher, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Oncotarget|January 20, 2017
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cellsAlison Roos, Harshil D Dhruv, Ian T Mathews, et al.
International Journal of Molecular Sciences|June 19, 2024
EGFRvIII Confers Sensitivity to Saracatinib in a STAT5-Dependent Manner in GlioblastomaMylan R Blomquist, Ryan Eghlimi, Angad Beniwal, et al.
Circulation Research|March 9, 2002
Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failureShaw-Yung Shai, Alice E Harpf, Christopher J Babbitt, et al.
Science Signaling|August 14, 2014
Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastomaYael Kusne, Eugenio A Carrera-Silva, Anthony S Perry, et al.
Cancer Research|October 5, 2006
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcomeNhan L Tran, Wendy S McDonough, Benjamin A Savitch, et al.
Journal of Translational Medicine|October 22, 2025
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppressionMylan R Blomquist, Teresa M R Noviello, Christopher Sereduk, et al.
Neuro-Oncology|August 10, 2016
Radiogenomics to characterize regional genetic heterogeneity in glioblastomaLeland S Hu, Shuluo Ning, Jennifer M Eschbacher, et al.
Pageof 5